Key facts
| Price (PPV) | 76,414 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | tafamidis |
| Class | Other nervous system drugs |
| ATC code | N07XX08 |
| Manufacturer | PFIZER MAROC |
| Presentation | Boite de 30 |
| Hospital price | 74,923 MAD |
| Data collected on | 9/8/2026 |
Indications
Vyndaqel est indiqué dans le traitement de l’amylose à transthyrétine (TTR) chez les patients adultes présentant une polyneuropathie symptomatique de stade 1 pour retarder le déficit neurologique périphérique. ( 26 novembre - https://ec.europa.eu )
Find an open pharmacy
On-call pharmacies near you
About Vyndaqel 61 mg
Vyndaqel 61 mg belongs to the other nervous system drugs therapeutic class. In Morocco, this drug is marketed by PFIZER MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Vyndaqel 61 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Vyndaqel 61 mg
Answers to common questions from Moroccan patients about this drug.